FI930821L - Bestaemning av maolkomponenter - Google Patents

Bestaemning av maolkomponenter Download PDF

Info

Publication number
FI930821L
FI930821L FI930821A FI930821A FI930821L FI 930821 L FI930821 L FI 930821L FI 930821 A FI930821 A FI 930821A FI 930821 A FI930821 A FI 930821A FI 930821 L FI930821 L FI 930821L
Authority
FI
Finland
Prior art keywords
maolkomponenter
bestaemning
Prior art date
Application number
FI930821A
Other languages
English (en)
Finnish (fi)
Other versions
FI930821A7 (fi
FI930821A0 (fi
Inventor
Robert A Levine
Stephen C Wardlaw
Rodolfo Rodriguez
Judith Britz
Thomas J Mercolino
Original Assignee
Robert A Levine
Stephen C Wardlaw
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert A Levine, Stephen C Wardlaw, Becton Dickinson Co filed Critical Robert A Levine
Publication of FI930821A0 publication Critical patent/FI930821A0/fi
Publication of FI930821A7 publication Critical patent/FI930821A7/fi
Publication of FI930821L publication Critical patent/FI930821L/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI930821A 1992-02-25 1993-02-24 Bestaemning av maolkomponenter FI930821L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84197692A 1992-02-25 1992-02-25

Publications (3)

Publication Number Publication Date
FI930821A0 FI930821A0 (fi) 1993-02-24
FI930821A7 FI930821A7 (fi) 1993-08-26
FI930821L true FI930821L (fi) 1993-08-26

Family

ID=25286232

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930821A FI930821L (fi) 1992-02-25 1993-02-24 Bestaemning av maolkomponenter

Country Status (17)

Country Link
US (1) US5593848A (cg-RX-API-DMAC7.html)
EP (1) EP0557595B1 (cg-RX-API-DMAC7.html)
JP (1) JP2925105B2 (cg-RX-API-DMAC7.html)
CN (1) CN1091521A (cg-RX-API-DMAC7.html)
AT (1) ATE155889T1 (cg-RX-API-DMAC7.html)
AU (1) AU662571B2 (cg-RX-API-DMAC7.html)
BR (1) BR9300639A (cg-RX-API-DMAC7.html)
CA (1) CA2090282A1 (cg-RX-API-DMAC7.html)
DE (1) DE69221118T2 (cg-RX-API-DMAC7.html)
DK (1) DK0557595T3 (cg-RX-API-DMAC7.html)
ES (1) ES2106121T3 (cg-RX-API-DMAC7.html)
FI (1) FI930821L (cg-RX-API-DMAC7.html)
GR (1) GR3024970T3 (cg-RX-API-DMAC7.html)
MX (1) MX9300965A (cg-RX-API-DMAC7.html)
NO (1) NO930649L (cg-RX-API-DMAC7.html)
RU (1) RU2116068C1 (cg-RX-API-DMAC7.html)
TW (1) TW246716B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342790A (en) * 1992-10-30 1994-08-30 Becton Dickinson And Company Apparatus for indirect fluorescent assay of blood samples
AU4101697A (en) * 1996-11-22 1998-05-28 Robert A. Levine Process for enhancing the aggregation and/or agglutination of erythrocytes prior to centrifugation
US6197523B1 (en) 1997-11-24 2001-03-06 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
AU9233698A (en) * 1997-11-22 1999-06-17 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood
US6911315B2 (en) * 1997-11-24 2005-06-28 David L. Rimm Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood
YU78600A (sh) * 1998-06-26 2002-11-15 Pfizer Products Inc. Poboljšani postupak dobijanja adukta schiff-ove baze amina sa 0-hidroksi aldehidima i na njima baziranih formulacija materijala
GB0021303D0 (en) * 2000-08-30 2000-10-18 Medinnova Sf Use
EP1576126A3 (en) * 2002-10-30 2005-10-26 Pointilliste, Inc. Systems for capture and analysis of biological particles and methods using the systems
JP2007528854A (ja) * 2003-07-09 2007-10-18 カリフォルニア パシフィック メディカル センター 細胞への物質送達の遠隔検出
US7996825B2 (en) * 2003-10-31 2011-08-09 Hewlett-Packard Development Company, L.P. Cross-file inlining by using summaries and global worklist
US20060018911A1 (en) * 2004-01-12 2006-01-26 Dana Ault-Riche Design of therapeutics and therapeutics
CA2720299C (en) * 2008-04-02 2015-02-17 Abbott Point Of Care, Inc. Self-calibrating gradient dilution in a constituent assay and gradient dilution apparatus performed in a thin film sample
WO2009126505A1 (en) * 2008-04-09 2009-10-15 Abbott Point Of Care, Inc. Method of detecting very low levels of analyte within a thin film fluid sample contained in a thin thickness chamber
FR2965273B1 (fr) * 2010-09-29 2015-07-17 Centre Nat Rech Scient Procede de preparation d'une structure chimique presentant une partition de phases, apte a generer un spectre de fluorescence specifique et ses applications
US9624474B2 (en) 2010-12-01 2017-04-18 Samsung Electronics Co, Ltd. Method of separating target cell in biological sample
CN102788879B (zh) * 2011-05-20 2015-04-01 常州康卫生物技术有限公司 一种生物检测试剂
CA2985135A1 (en) * 2015-05-06 2016-11-10 Seracare Life Sciences, Inc. Liposomal preparations for non-invasive-prenatal or cancer screening

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862303A (en) * 1972-02-02 1975-01-21 Atomic Energy Commission Method for rapid detection and identification of serological factors
US4027660A (en) * 1976-04-02 1977-06-07 Wardlaw Stephen C Material layer volume determination
US4181609A (en) * 1977-12-20 1980-01-01 Levine Robert A Blood constituents testing method
US4342739A (en) * 1979-01-09 1982-08-03 Fuji Photo Film Co., Ltd. Novel material for immunological assay of biochemical components and a process for the determination of said components
US4332785A (en) 1980-04-09 1982-06-01 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
IL64878A (en) * 1982-01-27 1986-01-31 Yissum Res Dev Co Method for detection of and determination of malaria antibodies and malaria antigens in human blood
JPS5984162A (ja) * 1982-11-05 1984-05-15 Toshiba Corp 免疫分析法
US4591570A (en) * 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
JPS6035267A (ja) * 1983-08-05 1985-02-23 Fuji Photo Film Co Ltd 多項目免疫検査法
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
FR2571498B1 (fr) * 1984-10-04 1988-04-08 Immunotech Sa Procede de separation de cellules utilisant des anticorps et des billes de faible densite
EP0241042A3 (en) * 1986-04-11 1988-05-04 Hitachi, Ltd. A method for cell analysis
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
GB2200448B (en) * 1987-01-23 1991-01-16 Univ London Targetted liposomes and their use in immunoassay
US5017472A (en) * 1987-09-09 1991-05-21 Bankert Richard B Microflotation devices used for immunoassays and cell/molecular fractionation
US4978625A (en) * 1987-10-19 1990-12-18 Becton, Dickinson And Company Fluorescence immunoassay using water insoluble dyes
GB2239197B (en) * 1989-12-22 1993-10-06 Syntex Inc Method for separating components in a mixture
JPH03249561A (ja) * 1990-02-28 1991-11-07 Toshiba Corp 免疫分析試薬

Also Published As

Publication number Publication date
ES2106121T3 (es) 1997-11-01
EP0557595A3 (cg-RX-API-DMAC7.html) 1993-11-10
BR9300639A (pt) 1993-08-31
TW246716B (cg-RX-API-DMAC7.html) 1995-05-01
FI930821A7 (fi) 1993-08-26
DE69221118T2 (de) 1998-02-26
NO930649D0 (no) 1993-02-24
RU2116068C1 (ru) 1998-07-27
AU662571B2 (en) 1995-09-07
CA2090282A1 (en) 1993-08-26
DK0557595T3 (da) 1997-12-29
GR3024970T3 (en) 1998-01-30
NO930649L (no) 1993-08-26
JP2925105B2 (ja) 1999-07-28
JPH0821833A (ja) 1996-01-23
CN1091521A (zh) 1994-08-31
US5593848A (en) 1997-01-14
MX9300965A (es) 1994-08-31
EP0557595A2 (en) 1993-09-01
FI930821A0 (fi) 1993-02-24
EP0557595B1 (en) 1997-07-23
DE69221118D1 (de) 1997-09-04
AU2983692A (en) 1993-08-26
ATE155889T1 (de) 1997-08-15

Similar Documents

Publication Publication Date Title
FI934804L (fi) Indirekt fluorescensanalys av blodprov
FI933583A0 (fi) Fabrikation av en glasaktig kiseldioxidprodukt
FI933573A7 (fi) Foerfarande foer framstaellning av polyolefiner
FI933619A0 (fi) En mekanism foer jaemn tvinning av en kabeltrumma
FI924590L (fi) Foerfarande foer framstaellning av laekemedelskorn
FI932012L (fi) Foerfarande foer framstaellning av arylpiperazinyl-heterocykliska foereningar
FI932655L (fi) Imidatderivat av farmaceutiskt anvaendbara antikonvulsiva sulfamat
FI935008L (fi) Selektrivt flotationsfoerfarande foer separering av sulfidmineraler
FI931603A0 (fi) Foerfarande foer framstaellning av bifenylderivat
FI933800A7 (fi) Klammer foer sammanbindande av kantprofiler foer skaolningsplattor
FI930821L (fi) Bestaemning av maolkomponenter
FI934799A0 (fi) Stroemningsreglerapparat av en aenddel foer en pappersmaskinsinloppslaoda
FI931032L (fi) Foerfarande foer framstaellning av klavulansyrasalter
FI931668A0 (fi) Cellrestprodukter av jaest
FI930800L (fi) Foerfarande foer avlaegsning av laett oxiderbara organiska foereningar fraon gasstroemmar
FI933486L (fi) Foerfarande foer acylering av 7-aminogrupp av kefalosporanring
FI932016A7 (fi) Anordning foer pervaporering av vaetskor
FI933264A0 (fi) Foerfarande foer framstaellning av fysostigminkarbamatderivat fraon fysostigmin
FI933079L (fi) Enzymatiskt foerfarande foer separering av racemiska blandningar av delta-valerolaktoner
FI935592A0 (fi) Foerfarande foer framstaellning av polypeptider
FI930710A7 (fi) Anordning foer oevervakning av vaetskenivao
FI932620L (fi) Framstaellning av blekningskemikalier foer cellulosamassa
FI931429L (fi) Foerfarande foer framstaellning av 4-substituerade azetidinonderivat
FI932570A7 (fi) Foerfarande foer framstaellning av 2-oxo-1-piperidinylderivat
FI21U1 (fi) Anordning foer uppskattning av avstaond